DEFINITIVE PROXY STATEMENT

Company

REGENERON PHARMACEUTICALS, INC.

Filed

April 28, 2008

Period of Report

June 13, 2008

Accession Number

0001206774-08-000874

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →